

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proteasome assembly (GO:0043248) | 5.49247506 |
| 2 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.41957749 |
| 3 | maturation of SSU-rRNA (GO:0030490) | 5.15704445 |
| 4 | ATP synthesis coupled proton transport (GO:0015986) | 4.98704036 |
| 5 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.98704036 |
| 6 | viral transcription (GO:0019083) | 4.96508446 |
| 7 | ribosomal small subunit assembly (GO:0000028) | 4.95469634 |
| 8 | ribosomal small subunit biogenesis (GO:0042274) | 4.93634306 |
| 9 | translational termination (GO:0006415) | 4.88227745 |
| 10 | * negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.83493567 |
| 11 | DNA deamination (GO:0045006) | 4.66773444 |
| 12 | ribosomal large subunit biogenesis (GO:0042273) | 4.60890874 |
| 13 | * positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.57458036 |
| 14 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.52215325 |
| 15 | cotranslational protein targeting to membrane (GO:0006613) | 4.50415242 |
| 16 | * regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.45564731 |
| 17 | protein targeting to ER (GO:0045047) | 4.44324403 |
| 18 | * regulation of cellular amino acid metabolic process (GO:0006521) | 4.44049746 |
| 19 | * negative regulation of ligase activity (GO:0051352) | 4.41499749 |
| 20 | * negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.41499749 |
| 21 | * anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 4.38158957 |
| 22 | * DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 4.32855066 |
| 23 | translational elongation (GO:0006414) | 4.26657005 |
| 24 | * intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 4.26026850 |
| 25 | * signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 4.26026850 |
| 26 | * antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 4.25443634 |
| 27 | protein localization to endoplasmic reticulum (GO:0070972) | 4.25332020 |
| 28 | formation of translation preinitiation complex (GO:0001731) | 4.22740738 |
| 29 | * signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 4.22337974 |
| 30 | * signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 4.22337974 |
| 31 | * signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 4.22337974 |
| 32 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.21568520 |
| 33 | translational initiation (GO:0006413) | 4.15090937 |
| 34 | * signal transduction involved in DNA integrity checkpoint (GO:0072401) | 4.12996506 |
| 35 | * signal transduction involved in DNA damage checkpoint (GO:0072422) | 4.12996506 |
| 36 | protein neddylation (GO:0045116) | 4.09915657 |
| 37 | * signal transduction involved in cell cycle checkpoint (GO:0072395) | 4.07051780 |
| 38 | 7-methylguanosine mRNA capping (GO:0006370) | 4.05757551 |
| 39 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 4.05110896 |
| 40 | termination of RNA polymerase III transcription (GO:0006386) | 4.05110896 |
| 41 | * antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 4.01339440 |
| 42 | establishment of integrated proviral latency (GO:0075713) | 4.00792272 |
| 43 | translation (GO:0006412) | 4.00304301 |
| 44 | RNA capping (GO:0036260) | 3.99466379 |
| 45 | 7-methylguanosine RNA capping (GO:0009452) | 3.99466379 |
| 46 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.97340524 |
| 47 | cullin deneddylation (GO:0010388) | 3.97082776 |
| 48 | * positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.95168352 |
| 49 | viral life cycle (GO:0019058) | 3.92376286 |
| 50 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.88781649 |
| 51 | cellular protein complex disassembly (GO:0043624) | 3.88569939 |
| 52 | protein deneddylation (GO:0000338) | 3.83550850 |
| 53 | * positive regulation of ligase activity (GO:0051351) | 3.80727281 |
| 54 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.77692138 |
| 55 | chaperone-mediated protein transport (GO:0072321) | 3.76610495 |
| 56 | histone exchange (GO:0043486) | 3.72871014 |
| 57 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.71023442 |
| 58 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.69232250 |
| 59 | spliceosomal snRNP assembly (GO:0000387) | 3.66608522 |
| 60 | DNA double-strand break processing (GO:0000729) | 3.62846741 |
| 61 | rRNA modification (GO:0000154) | 3.60992252 |
| 62 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.59211221 |
| 63 | regulation of mitochondrial translation (GO:0070129) | 3.58406828 |
| 64 | mitotic metaphase plate congression (GO:0007080) | 3.57554862 |
| 65 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.57232170 |
| 66 | rRNA processing (GO:0006364) | 3.56313594 |
| 67 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 3.55606852 |
| 68 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.54707104 |
| 69 | NADH dehydrogenase complex assembly (GO:0010257) | 3.54707104 |
| 70 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.54707104 |
| 71 | respiratory electron transport chain (GO:0022904) | 3.52684124 |
| 72 | protein complex biogenesis (GO:0070271) | 3.52419697 |
| 73 | ribosome assembly (GO:0042255) | 3.51008750 |
| 74 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.50888682 |
| 75 | CENP-A containing nucleosome assembly (GO:0034080) | 3.50834383 |
| 76 | cellular component biogenesis (GO:0044085) | 3.49957206 |
| 77 | DNA strand elongation (GO:0022616) | 3.49332887 |
| 78 | DNA replication-independent nucleosome organization (GO:0034724) | 3.49034360 |
| 79 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.49034360 |
| 80 | establishment of viral latency (GO:0019043) | 3.48135193 |
| 81 | DNA replication checkpoint (GO:0000076) | 3.46355541 |
| 82 | * regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.46105936 |
| 83 | termination of RNA polymerase I transcription (GO:0006363) | 3.44368610 |
| 84 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.44069111 |
| 85 | electron transport chain (GO:0022900) | 3.44019535 |
| 86 | rRNA metabolic process (GO:0016072) | 3.41440822 |
| 87 | nucleobase biosynthetic process (GO:0046112) | 3.39446544 |
| 88 | purine nucleobase biosynthetic process (GO:0009113) | 3.38908233 |
| 89 | * positive regulation of cell cycle arrest (GO:0071158) | 3.38506857 |
| 90 | DNA replication initiation (GO:0006270) | 3.38142151 |
| 91 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.38088062 |
| 92 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.36745660 |
| 93 | * DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.36682682 |
| 94 | * regulation of ligase activity (GO:0051340) | 3.36201715 |
| 95 | chromatin remodeling at centromere (GO:0031055) | 3.34444114 |
| 96 | establishment of protein localization to mitochondrion (GO:0072655) | 3.31290637 |
| 97 | transcription from RNA polymerase I promoter (GO:0006360) | 3.31169771 |
| 98 | * negative regulation of protein ubiquitination (GO:0031397) | 3.30510189 |
| 99 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.30306440 |
| 100 | * regulation of cellular amine metabolic process (GO:0033238) | 3.30271704 |
| 101 | spliceosomal complex assembly (GO:0000245) | 3.30222748 |
| 102 | pseudouridine synthesis (GO:0001522) | 3.30093905 |
| 103 | * cell cycle G1/S phase transition (GO:0044843) | 3.29197554 |
| 104 | * G1/S transition of mitotic cell cycle (GO:0000082) | 3.29197554 |
| 105 | protein targeting to mitochondrion (GO:0006626) | 3.29070461 |
| 106 | protein complex disassembly (GO:0043241) | 3.28609471 |
| 107 | respiratory chain complex IV assembly (GO:0008535) | 3.26376650 |
| 108 | * antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 3.26090122 |
| 109 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.26006714 |
| 110 | telomere maintenance via recombination (GO:0000722) | 3.25905550 |
| 111 | oxidative phosphorylation (GO:0006119) | 3.25730998 |
| 112 | DNA damage response, detection of DNA damage (GO:0042769) | 3.25664033 |
| 113 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.25226203 |
| 114 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.25226203 |
| 115 | ribosome biogenesis (GO:0042254) | 3.24464860 |
| 116 | DNA ligation (GO:0006266) | 3.24311044 |
| 117 | IMP biosynthetic process (GO:0006188) | 3.21618075 |
| 118 | histone mRNA metabolic process (GO:0008334) | 3.19459414 |
| 119 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.19104440 |
| 120 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.19104440 |
| 121 | protein localization to kinetochore (GO:0034501) | 3.17197292 |
| 122 | protein localization to mitochondrion (GO:0070585) | 3.16170371 |
| 123 | mitotic recombination (GO:0006312) | 3.15603707 |
| 124 | metaphase plate congression (GO:0051310) | 3.13970699 |
| 125 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.09740159 |
| 126 | kinetochore organization (GO:0051383) | 3.09294001 |
| 127 | * negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 3.07625895 |
| 128 | rRNA methylation (GO:0031167) | 3.07313877 |
| 129 | spindle checkpoint (GO:0031577) | 3.05229893 |
| 130 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 3.04217297 |
| 131 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 3.04217297 |
| 132 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 3.04217297 |
| 133 | negative regulation of sister chromatid segregation (GO:0033046) | 3.04217297 |
| 134 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 3.04217297 |
| 135 | kinetochore assembly (GO:0051382) | 3.03863777 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.10305451 |
| 2 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.81788363 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.58180238 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.47463845 |
| 5 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 4.21161717 |
| 6 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.97515443 |
| 7 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.84434503 |
| 8 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.67400188 |
| 9 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.60728379 |
| 10 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.60543581 |
| 11 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.46205522 |
| 12 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.24666568 |
| 13 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 3.18885245 |
| 14 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.12494671 |
| 15 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.06613220 |
| 16 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.93931033 |
| 17 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.93460639 |
| 18 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.81591338 |
| 19 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.81120794 |
| 20 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.78801370 |
| 21 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.62364275 |
| 22 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.47587110 |
| 23 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 2.45621526 |
| 24 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.42815511 |
| 25 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.39797134 |
| 26 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.38970398 |
| 27 | * CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.38946512 |
| 28 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.29169982 |
| 29 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.20725085 |
| 30 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.20516963 |
| 31 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.11129159 |
| 32 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.10968778 |
| 33 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.10898175 |
| 34 | TTF2_22483619_ChIP-Seq_HELA_Human | 2.07242443 |
| 35 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.92961426 |
| 36 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.92174490 |
| 37 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.80099218 |
| 38 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.78878129 |
| 39 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.78319029 |
| 40 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.77175048 |
| 41 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.76936875 |
| 42 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.74046138 |
| 43 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.66556401 |
| 44 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.65274509 |
| 45 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.62432577 |
| 46 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.60508436 |
| 47 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.58302199 |
| 48 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.57966302 |
| 49 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.54881118 |
| 50 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46104551 |
| 51 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45516164 |
| 52 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.41641043 |
| 53 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.41363478 |
| 54 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.40808534 |
| 55 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.38632103 |
| 56 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.33729775 |
| 57 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.33124563 |
| 58 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.32629503 |
| 59 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.32041546 |
| 60 | EWS_26573619_Chip-Seq_HEK293_Human | 1.28555578 |
| 61 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.25191179 |
| 62 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.24487569 |
| 63 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.17874616 |
| 64 | VDR_22108803_ChIP-Seq_LS180_Human | 1.17812931 |
| 65 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.15258834 |
| 66 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.13092515 |
| 67 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.12092090 |
| 68 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11523965 |
| 69 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.10830596 |
| 70 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.08786627 |
| 71 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.08619286 |
| 72 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.06813289 |
| 73 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.06667537 |
| 74 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.04793129 |
| 75 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.01699164 |
| 76 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.00901373 |
| 77 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.00753161 |
| 78 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.00184136 |
| 79 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.97434274 |
| 80 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.97196557 |
| 81 | FUS_26573619_Chip-Seq_HEK293_Human | 0.96500434 |
| 82 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.93674507 |
| 83 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93115157 |
| 84 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.93041650 |
| 85 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.92884338 |
| 86 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.89727602 |
| 87 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.89317541 |
| 88 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.89265174 |
| 89 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.88971018 |
| 90 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.87263297 |
| 91 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.86997750 |
| 92 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 0.85272582 |
| 93 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.82942687 |
| 94 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.82877073 |
| 95 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82773655 |
| 96 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.82202317 |
| 97 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.81459574 |
| 98 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.80162958 |
| 99 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.79306264 |
| 100 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.78160369 |
| 101 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.77647130 |
| 102 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.76390898 |
| 103 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.75803118 |
| 104 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.73640540 |
| 105 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.72499196 |
| 106 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.71782042 |
| 107 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.70883217 |
| 108 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.70696552 |
| 109 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.69773936 |
| 110 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.69767496 |
| 111 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.66455086 |
| 112 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.65892919 |
| 113 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.65356852 |
| 114 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.65096013 |
| 115 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.64842895 |
| 116 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.64237218 |
| 117 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.64075728 |
| 118 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.63593166 |
| 119 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.63156899 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 5.36346819 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 4.67838238 |
| 3 | MP0010094_abnormal_chromosome_stability | 3.69649848 |
| 4 | MP0003077_abnormal_cell_cycle | 3.48178216 |
| 5 | MP0008057_abnormal_DNA_replication | 3.33149483 |
| 6 | MP0003111_abnormal_nucleus_morphology | 3.28571939 |
| 7 | MP0008058_abnormal_DNA_repair | 3.24891789 |
| 8 | MP0008932_abnormal_embryonic_tissue | 3.18368605 |
| 9 | MP0009379_abnormal_foot_pigmentation | 3.12343325 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 3.01412413 |
| 11 | MP0003718_maternal_effect | 2.93341675 |
| 12 | MP0003941_abnormal_skin_development | 2.64110886 |
| 13 | MP0003186_abnormal_redox_activity | 2.56101151 |
| 14 | MP0001529_abnormal_vocalization | 2.41613967 |
| 15 | MP0003786_premature_aging | 2.40111819 |
| 16 | MP0008007_abnormal_cellular_replicative | 2.36354038 |
| 17 | MP0003123_paternal_imprinting | 2.08461097 |
| 18 | MP0008877_abnormal_DNA_methylation | 2.00675289 |
| 19 | MP0003890_abnormal_embryonic-extraembry | 1.80816261 |
| 20 | MP0006036_abnormal_mitochondrial_physio | 1.80483308 |
| 21 | MP0001730_embryonic_growth_arrest | 1.75990739 |
| 22 | MP0009333_abnormal_splenocyte_physiolog | 1.75879520 |
| 23 | MP0001905_abnormal_dopamine_level | 1.69000114 |
| 24 | MP0003315_abnormal_perineum_morphology | 1.58582838 |
| 25 | MP0006035_abnormal_mitochondrial_morpho | 1.57891530 |
| 26 | MP0003136_yellow_coat_color | 1.52850600 |
| 27 | MP0000350_abnormal_cell_proliferation | 1.52122431 |
| 28 | MP0002638_abnormal_pupillary_reflex | 1.47151524 |
| 29 | MP0005408_hypopigmentation | 1.41327916 |
| 30 | MP0002938_white_spotting | 1.40798892 |
| 31 | MP0008260_abnormal_autophagy | 1.40764162 |
| 32 | MP0006292_abnormal_olfactory_placode | 1.38899549 |
| 33 | MP0002132_abnormal_respiratory_system | 1.36931697 |
| 34 | MP0002148_abnormal_hypersensitivity_rea | 1.35598423 |
| 35 | MP0000490_abnormal_crypts_of | 1.27675044 |
| 36 | MP0002254_reproductive_system_inflammat | 1.25789060 |
| 37 | MP0002163_abnormal_gland_morphology | 1.25494446 |
| 38 | MP0000372_irregular_coat_pigmentation | 1.24835605 |
| 39 | MP0008875_abnormal_xenobiotic_pharmacok | 1.23194551 |
| 40 | MP0002736_abnormal_nociception_after | 1.22757942 |
| 41 | MP0000313_abnormal_cell_death | 1.20222748 |
| 42 | MP0005084_abnormal_gallbladder_morpholo | 1.19669042 |
| 43 | MP0005394_taste/olfaction_phenotype | 1.19052178 |
| 44 | MP0005499_abnormal_olfactory_system | 1.19052178 |
| 45 | MP0009785_altered_susceptibility_to | 1.17280163 |
| 46 | MP0001727_abnormal_embryo_implantation | 1.16626195 |
| 47 | MP0001697_abnormal_embryo_size | 1.12135800 |
| 48 | MP0001986_abnormal_taste_sensitivity | 1.10912065 |
| 49 | MP0001853_heart_inflammation | 1.10895872 |
| 50 | MP0005671_abnormal_response_to | 1.10737671 |
| 51 | MP0003763_abnormal_thymus_physiology | 1.09717360 |
| 52 | MP0009697_abnormal_copulation | 1.09195200 |
| 53 | MP0010030_abnormal_orbit_morphology | 1.08767576 |
| 54 | MP0002019_abnormal_tumor_incidence | 1.07908046 |
| 55 | MP0002080_prenatal_lethality | 1.05899531 |
| 56 | MP0002090_abnormal_vision | 1.05426150 |
| 57 | MP0003195_calcinosis | 1.05164786 |
| 58 | MP0002160_abnormal_reproductive_system | 1.05114358 |
| 59 | MP0002102_abnormal_ear_morphology | 1.04686641 |
| 60 | MP0003724_increased_susceptibility_to | 1.03165934 |
| 61 | MP0001542_abnormal_bone_strength | 1.03075568 |
| 62 | MP0008789_abnormal_olfactory_epithelium | 1.02935556 |
| 63 | MP0000358_abnormal_cell_content/ | 1.02565264 |
| 64 | MP0003567_abnormal_fetal_cardiomyocyte | 1.02091564 |
| 65 | MP0004133_heterotaxia | 1.00585788 |
| 66 | MP0003937_abnormal_limbs/digits/tail_de | 1.00437896 |
| 67 | MP0005389_reproductive_system_phenotype | 0.98055307 |
| 68 | MP0002210_abnormal_sex_determination | 0.97283574 |
| 69 | MP0004215_abnormal_myocardial_fiber | 0.95423642 |
| 70 | MP0008995_early_reproductive_senescence | 0.94695702 |
| 71 | MP0001835_abnormal_antigen_presentation | 0.94548622 |
| 72 | MP0002396_abnormal_hematopoietic_system | 0.92434922 |
| 73 | MP0000566_synostosis | 0.92055841 |
| 74 | MP0000647_abnormal_sebaceous_gland | 0.91810162 |
| 75 | MP0005253_abnormal_eye_physiology | 0.91396601 |
| 76 | MP0008872_abnormal_physiological_respon | 0.91202789 |
| 77 | MP0003011_delayed_dark_adaptation | 0.90321215 |
| 78 | MP0002084_abnormal_developmental_patter | 0.90111733 |
| 79 | MP0005395_other_phenotype | 0.89826139 |
| 80 | MP0002722_abnormal_immune_system | 0.89307373 |
| 81 | MP0002751_abnormal_autonomic_nervous | 0.89147751 |
| 82 | MP0004381_abnormal_hair_follicle | 0.88718643 |
| 83 | MP0001286_abnormal_eye_development | 0.88072692 |
| 84 | MP0004147_increased_porphyrin_level | 0.87960724 |
| 85 | MP0005075_abnormal_melanosome_morpholog | 0.86990331 |
| 86 | MP0001188_hyperpigmentation | 0.86844173 |
| 87 | MP0000689_abnormal_spleen_morphology | 0.86787470 |
| 88 | MP0002398_abnormal_bone_marrow | 0.85730375 |
| 89 | MP0001984_abnormal_olfaction | 0.84486840 |
| 90 | MP0002277_abnormal_respiratory_mucosa | 0.84125025 |
| 91 | MP0001881_abnormal_mammary_gland | 0.82783094 |
| 92 | MP0002233_abnormal_nose_morphology | 0.82771539 |
| 93 | MP0002837_dystrophic_cardiac_calcinosis | 0.82460306 |
| 94 | MP0006054_spinal_hemorrhage | 0.82448685 |
| 95 | MP0001672_abnormal_embryogenesis/_devel | 0.80385148 |
| 96 | MP0005380_embryogenesis_phenotype | 0.80385148 |
| 97 | MP0001145_abnormal_male_reproductive | 0.80334021 |
| 98 | MP0000703_abnormal_thymus_morphology | 0.79810582 |
| 99 | MP0002429_abnormal_blood_cell | 0.79609039 |
| 100 | MP0009672_abnormal_birth_weight | 0.77973480 |
| 101 | MP0005000_abnormal_immune_tolerance | 0.77868839 |
| 102 | MP0002085_abnormal_embryonic_tissue | 0.77577480 |
| 103 | MP0005332_abnormal_amino_acid | 0.75831085 |
| 104 | MP0005025_abnormal_response_to | 0.73970616 |
| 105 | MP0002420_abnormal_adaptive_immunity | 0.73254652 |
| 106 | MP0003119_abnormal_digestive_system | 0.72993619 |
| 107 | MP0000716_abnormal_immune_system | 0.72210180 |
| 108 | MP0001819_abnormal_immune_cell | 0.72073736 |
| 109 | MP0000653_abnormal_sex_gland | 0.71349186 |
| 110 | MP0001764_abnormal_homeostasis | 0.68544018 |
| 111 | MP0001919_abnormal_reproductive_system | 0.68422556 |
| 112 | MP0001485_abnormal_pinna_reflex | 0.68311476 |
| 113 | MP0001929_abnormal_gametogenesis | 0.68106506 |
| 114 | MP0002723_abnormal_immune_serum | 0.67910858 |
| 115 | MP0002111_abnormal_tail_morphology | 0.67880482 |
| 116 | MP0000858_altered_metastatic_potential | 0.67314051 |
| 117 | MP0006276_abnormal_autonomic_nervous | 0.67310003 |
| 118 | MP0005266_abnormal_metabolism | 0.67202592 |
| 119 | MP0003121_genomic_imprinting | 0.66088383 |
| 120 | MP0010307_abnormal_tumor_latency | 0.65865855 |
| 121 | MP0003221_abnormal_cardiomyocyte_apopto | 0.65787031 |
| 122 | MP0003984_embryonic_growth_retardation | 0.65393407 |
| 123 | MP0001119_abnormal_female_reproductive | 0.65129184 |
| 124 | MP0002452_abnormal_antigen_presenting | 0.63763110 |
| 125 | MP0006072_abnormal_retinal_apoptosis | 0.63730777 |
| 126 | MP0001293_anophthalmia | 0.63650940 |
| 127 | MP0008873_increased_physiological_sensi | 0.63241200 |
| 128 | MP0005410_abnormal_fertilization | 0.62481536 |
| 129 | MP0002405_respiratory_system_inflammati | 0.61765750 |
| 130 | MP0002088_abnormal_embryonic_growth/wei | 0.60713350 |
| 131 | MP0010386_abnormal_urinary_bladder | 0.60643012 |
| 132 | MP0004142_abnormal_muscle_tone | 0.58992458 |
| 133 | MP0005636_abnormal_mineral_homeostasis | 0.57877597 |
| 134 | MP0000049_abnormal_middle_ear | 0.56569426 |
| 135 | MP0003950_abnormal_plasma_membrane | 0.54248484 |
| 136 | MP0005551_abnormal_eye_electrophysiolog | 0.53157926 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 5.47573081 |
| 2 | Mitochondrial inheritance (HP:0001427) | 4.94526466 |
| 3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.88951001 |
| 4 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.84601633 |
| 5 | Increased hepatocellular lipid droplets (HP:0006565) | 4.42571808 |
| 6 | Abnormal number of erythroid precursors (HP:0012131) | 4.41021784 |
| 7 | Progressive macrocephaly (HP:0004481) | 4.40377753 |
| 8 | Increased CSF lactate (HP:0002490) | 4.39405932 |
| 9 | Birth length less than 3rd percentile (HP:0003561) | 4.30553876 |
| 10 | Acute encephalopathy (HP:0006846) | 4.28484789 |
| 11 | Hepatocellular necrosis (HP:0001404) | 4.26423607 |
| 12 | Reticulocytopenia (HP:0001896) | 4.19066463 |
| 13 | Increased serum pyruvate (HP:0003542) | 4.04297286 |
| 14 | Abnormality of glycolysis (HP:0004366) | 4.04297286 |
| 15 | Lipid accumulation in hepatocytes (HP:0006561) | 3.88700612 |
| 16 | Hepatic necrosis (HP:0002605) | 3.70681462 |
| 17 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.67633312 |
| 18 | Macrocytic anemia (HP:0001972) | 3.66070031 |
| 19 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.64796047 |
| 20 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.64796047 |
| 21 | Breast hypoplasia (HP:0003187) | 3.63219275 |
| 22 | Cerebral hypomyelination (HP:0006808) | 3.54476407 |
| 23 | 3-Methylglutaconic aciduria (HP:0003535) | 3.53610822 |
| 24 | Renal Fanconi syndrome (HP:0001994) | 3.49517659 |
| 25 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.40648019 |
| 26 | Increased serum lactate (HP:0002151) | 3.40177373 |
| 27 | Exertional dyspnea (HP:0002875) | 3.27371305 |
| 28 | Abnormality of methionine metabolism (HP:0010901) | 3.14800679 |
| 29 | Exercise intolerance (HP:0003546) | 3.11821838 |
| 30 | Respiratory failure (HP:0002878) | 3.05216931 |
| 31 | Pallor (HP:0000980) | 3.01300929 |
| 32 | Rough bone trabeculation (HP:0100670) | 3.00526791 |
| 33 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.97752076 |
| 34 | Oral leukoplakia (HP:0002745) | 2.95647766 |
| 35 | Methylmalonic acidemia (HP:0002912) | 2.87380903 |
| 36 | Cerebral edema (HP:0002181) | 2.87098669 |
| 37 | Increased intramyocellular lipid droplets (HP:0012240) | 2.86262251 |
| 38 | Lactic acidosis (HP:0003128) | 2.85114683 |
| 39 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.84388608 |
| 40 | Abnormality of the labia minora (HP:0012880) | 2.78917426 |
| 41 | Leukodystrophy (HP:0002415) | 2.75538264 |
| 42 | Carpal bone hypoplasia (HP:0001498) | 2.75245429 |
| 43 | Aplastic anemia (HP:0001915) | 2.73514603 |
| 44 | Respiratory difficulties (HP:0002880) | 2.71165577 |
| 45 | Type I transferrin isoform profile (HP:0003642) | 2.68325702 |
| 46 | Reduced antithrombin III activity (HP:0001976) | 2.66888480 |
| 47 | Methylmalonic aciduria (HP:0012120) | 2.64919064 |
| 48 | Abnormality of the ileum (HP:0001549) | 2.62748531 |
| 49 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.58845270 |
| 50 | Multiple enchondromatosis (HP:0005701) | 2.57181218 |
| 51 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.55900416 |
| 52 | Parakeratosis (HP:0001036) | 2.54735830 |
| 53 | Abnormality of serum amino acid levels (HP:0003112) | 2.52821435 |
| 54 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.51086740 |
| 55 | Abnormality of chromosome stability (HP:0003220) | 2.50296529 |
| 56 | Poor head control (HP:0002421) | 2.50295725 |
| 57 | Abnormality of the anterior horn cell (HP:0006802) | 2.48139515 |
| 58 | Degeneration of anterior horn cells (HP:0002398) | 2.48139515 |
| 59 | Lethargy (HP:0001254) | 2.47778728 |
| 60 | Chromsome breakage (HP:0040012) | 2.47450877 |
| 61 | Optic disc pallor (HP:0000543) | 2.40625499 |
| 62 | Abnormal lung lobation (HP:0002101) | 2.40022567 |
| 63 | Stenosis of the external auditory canal (HP:0000402) | 2.38593855 |
| 64 | Microretrognathia (HP:0000308) | 2.35725956 |
| 65 | Microvesicular hepatic steatosis (HP:0001414) | 2.34373683 |
| 66 | Abnormal trabecular bone morphology (HP:0100671) | 2.33380995 |
| 67 | Secondary amenorrhea (HP:0000869) | 2.32429958 |
| 68 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.27846342 |
| 69 | Abnormality of alanine metabolism (HP:0010916) | 2.27846342 |
| 70 | Hyperalaninemia (HP:0003348) | 2.27846342 |
| 71 | Increased muscle lipid content (HP:0009058) | 2.27146528 |
| 72 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.26374310 |
| 73 | CNS demyelination (HP:0007305) | 2.25405997 |
| 74 | Trismus (HP:0000211) | 2.25024164 |
| 75 | Premature graying of hair (HP:0002216) | 2.24751040 |
| 76 | Megaloblastic anemia (HP:0001889) | 2.23690854 |
| 77 | CNS hypomyelination (HP:0003429) | 2.18407612 |
| 78 | Abnormality of renal resorption (HP:0011038) | 2.15165192 |
| 79 | Hyperglycinemia (HP:0002154) | 2.13484668 |
| 80 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.12595883 |
| 81 | Emotional lability (HP:0000712) | 2.12436141 |
| 82 | Patellar aplasia (HP:0006443) | 2.12087166 |
| 83 | Generalized aminoaciduria (HP:0002909) | 2.10786807 |
| 84 | Cleft eyelid (HP:0000625) | 2.10110025 |
| 85 | Absent radius (HP:0003974) | 2.07327478 |
| 86 | IgM deficiency (HP:0002850) | 2.05247918 |
| 87 | Duodenal stenosis (HP:0100867) | 2.04843790 |
| 88 | Small intestinal stenosis (HP:0012848) | 2.04843790 |
| 89 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.04230123 |
| 90 | Cellular immunodeficiency (HP:0005374) | 2.03346988 |
| 91 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.02961306 |
| 92 | Delusions (HP:0000746) | 2.01719574 |
| 93 | Postnatal microcephaly (HP:0005484) | 2.00267672 |
| 94 | Septo-optic dysplasia (HP:0100842) | 1.99801165 |
| 95 | Glossoptosis (HP:0000162) | 1.99278291 |
| 96 | Horseshoe kidney (HP:0000085) | 1.97856289 |
| 97 | Absent forearm bone (HP:0003953) | 1.94972977 |
| 98 | Aplasia involving forearm bones (HP:0009822) | 1.94972977 |
| 99 | Pancytopenia (HP:0001876) | 1.92407579 |
| 100 | Premature ovarian failure (HP:0008209) | 1.92350212 |
| 101 | Abnormality of placental membranes (HP:0011409) | 1.91716083 |
| 102 | Amniotic constriction ring (HP:0009775) | 1.91716083 |
| 103 | Sparse eyelashes (HP:0000653) | 1.91511053 |
| 104 | Glycosuria (HP:0003076) | 1.89224676 |
| 105 | Abnormality of urine glucose concentration (HP:0011016) | 1.89224676 |
| 106 | Absent thumb (HP:0009777) | 1.89133434 |
| 107 | Congenital, generalized hypertrichosis (HP:0004540) | 1.87288793 |
| 108 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.84779478 |
| 109 | Abnormality of the preputium (HP:0100587) | 1.84184413 |
| 110 | Abnormality of the duodenum (HP:0002246) | 1.84178144 |
| 111 | X-linked dominant inheritance (HP:0001423) | 1.83371413 |
| 112 | Abnormal protein glycosylation (HP:0012346) | 1.83001349 |
| 113 | Abnormal glycosylation (HP:0012345) | 1.83001349 |
| 114 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.83001349 |
| 115 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.83001349 |
| 116 | Irregular epiphyses (HP:0010582) | 1.82386850 |
| 117 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.82358029 |
| 118 | Neoplasm of the adrenal gland (HP:0100631) | 1.81962705 |
| 119 | Median cleft lip (HP:0000161) | 1.80503068 |
| 120 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.78489266 |
| 121 | Triphalangeal thumb (HP:0001199) | 1.77773748 |
| 122 | Absent septum pellucidum (HP:0001331) | 1.77725870 |
| 123 | Neoplasm of the colon (HP:0100273) | 1.77418182 |
| 124 | Type 2 muscle fiber atrophy (HP:0003554) | 1.75704542 |
| 125 | Abnormality of vitamin B metabolism (HP:0004340) | 1.74838421 |
| 126 | Abnormality of glycine metabolism (HP:0010895) | 1.73514876 |
| 127 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.73514876 |
| 128 | Meckel diverticulum (HP:0002245) | 1.72799302 |
| 129 | Pancreatic cysts (HP:0001737) | 1.71256138 |
| 130 | Muscle fiber atrophy (HP:0100295) | 1.69733788 |
| 131 | Agnosia (HP:0010524) | 1.69310931 |
| 132 | Colon cancer (HP:0003003) | 1.68725252 |
| 133 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.68664487 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.98065522 |
| 2 | EIF2AK1 | 3.81821828 |
| 3 | VRK2 | 3.75645222 |
| 4 | STK16 | 3.65691288 |
| 5 | WEE1 | 3.64424583 |
| 6 | NME2 | 3.42802207 |
| 7 | PBK | 3.11839009 |
| 8 | SRPK1 | 2.63726255 |
| 9 | EIF2AK3 | 2.58444785 |
| 10 | MST4 | 2.35267857 |
| 11 | TESK2 | 2.34235890 |
| 12 | VRK1 | 2.30123131 |
| 13 | TRIM28 | 2.28656263 |
| 14 | NME1 | 2.24400140 |
| 15 | CDC7 | 2.07989143 |
| 16 | PLK4 | 2.06395423 |
| 17 | TSSK6 | 1.99546835 |
| 18 | PIM2 | 1.89571368 |
| 19 | TLK1 | 1.89501816 |
| 20 | ACVR1B | 1.71598502 |
| 21 | ARAF | 1.70441263 |
| 22 | NUAK1 | 1.65491623 |
| 23 | KDR | 1.61871463 |
| 24 | TNIK | 1.49356624 |
| 25 | LIMK1 | 1.44334216 |
| 26 | MKNK1 | 1.40812588 |
| 27 | BRSK2 | 1.34561802 |
| 28 | PNCK | 1.33392329 |
| 29 | MAP3K12 | 1.32842757 |
| 30 | PLK3 | 1.30268173 |
| 31 | PLK1 | 1.30169679 |
| 32 | MAP4K2 | 1.28277155 |
| 33 | TESK1 | 1.25445157 |
| 34 | AURKA | 1.24230598 |
| 35 | DYRK3 | 1.21372189 |
| 36 | DYRK2 | 1.21371653 |
| 37 | BRAF | 1.20794872 |
| 38 | TAF1 | 1.18888798 |
| 39 | AURKB | 1.17069031 |
| 40 | TTK | 1.13660053 |
| 41 | PDK2 | 1.13284204 |
| 42 | BCR | 1.06148898 |
| 43 | EPHA2 | 1.04209171 |
| 44 | RPS6KB2 | 0.96346397 |
| 45 | ZAK | 0.93061742 |
| 46 | ABL2 | 0.91734634 |
| 47 | BMPR2 | 0.89903999 |
| 48 | CDK19 | 0.89534401 |
| 49 | EIF2AK2 | 0.88806315 |
| 50 | PASK | 0.88458041 |
| 51 | CDK7 | 0.87672997 |
| 52 | MKNK2 | 0.87486680 |
| 53 | CSNK1G2 | 0.77723062 |
| 54 | CSNK2A1 | 0.75926102 |
| 55 | BMPR1B | 0.75384909 |
| 56 | NEK1 | 0.75146471 |
| 57 | PAK1 | 0.74352599 |
| 58 | CDK8 | 0.74042282 |
| 59 | CSNK2A2 | 0.71752182 |
| 60 | BLK | 0.71531588 |
| 61 | CHEK2 | 0.71243457 |
| 62 | DAPK1 | 0.71209274 |
| 63 | RPS6KA5 | 0.71181086 |
| 64 | ATR | 0.70828930 |
| 65 | CCNB1 | 0.70776239 |
| 66 | CSNK1A1L | 0.70071458 |
| 67 | MYLK | 0.68765553 |
| 68 | ILK | 0.68268656 |
| 69 | BRSK1 | 0.67823911 |
| 70 | NEK2 | 0.66901289 |
| 71 | CSNK1G3 | 0.66079220 |
| 72 | SCYL2 | 0.65679469 |
| 73 | MAP3K11 | 0.64367363 |
| 74 | STK38L | 0.63698858 |
| 75 | RPS6KA4 | 0.63176170 |
| 76 | LRRK2 | 0.61702412 |
| 77 | ERBB3 | 0.60655514 |
| 78 | IRAK4 | 0.58816723 |
| 79 | MAP3K8 | 0.58699941 |
| 80 | GRK1 | 0.58352206 |
| 81 | STK24 | 0.57645882 |
| 82 | ERBB4 | 0.57515790 |
| 83 | PAK4 | 0.57061577 |
| 84 | STK4 | 0.55206664 |
| 85 | FLT3 | 0.55018381 |
| 86 | PIK3CG | 0.53797010 |
| 87 | TXK | 0.53510737 |
| 88 | ALK | 0.50731041 |
| 89 | ADRBK2 | 0.48869087 |
| 90 | BCKDK | 0.47775838 |
| 91 | GRK7 | 0.46618277 |
| 92 | PRKCI | 0.46333702 |
| 93 | CHEK1 | 0.45404112 |
| 94 | STK10 | 0.42652488 |
| 95 | MAPKAPK3 | 0.41308159 |
| 96 | STK39 | 0.40436476 |
| 97 | TGFBR1 | 0.40314874 |
| 98 | CLK1 | 0.40304672 |
| 99 | OXSR1 | 0.39257581 |
| 100 | STK3 | 0.39168342 |
| 101 | TEC | 0.36917558 |
| 102 | MOS | 0.36800274 |
| 103 | MAP2K7 | 0.36544303 |
| 104 | LYN | 0.35061999 |
| 105 | PIM1 | 0.34614553 |
| 106 | YES1 | 0.33691547 |
| 107 | SIK3 | 0.33307024 |
| 108 | DAPK3 | 0.32406093 |
| 109 | CSNK1G1 | 0.29779807 |
| 110 | NLK | 0.28807179 |
| 111 | INSRR | 0.28656093 |
| 112 | MUSK | 0.27452961 |
| 113 | CSNK1E | 0.27450464 |
| 114 | TIE1 | 0.27217165 |
| 115 | WNK3 | 0.27016829 |
| 116 | RAF1 | 0.26942066 |
| 117 | IKBKB | 0.26749813 |
| 118 | CDK14 | 0.26178951 |
| 119 | PLK2 | 0.25652383 |
| 120 | MAP3K4 | 0.25208051 |
| 121 | IRAK3 | 0.24865062 |
| 122 | MAP3K3 | 0.24791680 |
| 123 | ATM | 0.24332235 |
| 124 | MINK1 | 0.23612474 |
| 125 | NEK6 | 0.23211252 |
| 126 | CDK2 | 0.23169946 |
| 127 | CDK1 | 0.22849768 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Proteasome_Homo sapiens_hsa03050 | 5.54208014 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 4.77670099 |
| 3 | RNA polymerase_Homo sapiens_hsa03020 | 3.87525057 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 3.42436402 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.40143300 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 2.99309111 |
| 7 | Parkinsons disease_Homo sapiens_hsa05012 | 2.98019577 |
| 8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.97665183 |
| 9 | Spliceosome_Homo sapiens_hsa03040 | 2.73911507 |
| 10 | Protein export_Homo sapiens_hsa03060 | 2.68539497 |
| 11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.49839974 |
| 12 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.41628923 |
| 13 | Huntingtons disease_Homo sapiens_hsa05016 | 2.32167460 |
| 14 | Homologous recombination_Homo sapiens_hsa03440 | 2.29609256 |
| 15 | RNA transport_Homo sapiens_hsa03013 | 2.20819828 |
| 16 | Base excision repair_Homo sapiens_hsa03410 | 2.03229285 |
| 17 | Alzheimers disease_Homo sapiens_hsa05010 | 1.99053158 |
| 18 | Basal transcription factors_Homo sapiens_hsa03022 | 1.98691469 |
| 19 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.72106763 |
| 20 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.63968665 |
| 21 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.63408037 |
| 22 | RNA degradation_Homo sapiens_hsa03018 | 1.58267690 |
| 23 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.56671339 |
| 24 | Cell cycle_Homo sapiens_hsa04110 | 1.54633574 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.53506656 |
| 26 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.50860775 |
| 27 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.38132551 |
| 28 | Purine metabolism_Homo sapiens_hsa00230 | 1.37385494 |
| 29 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.32064254 |
| 30 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.28966376 |
| 31 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.24487603 |
| 32 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.20021277 |
| 33 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.19248582 |
| 34 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.09005156 |
| 35 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.07255923 |
| 36 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.93636168 |
| 37 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.92700067 |
| 38 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.91986348 |
| 39 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.90224528 |
| 40 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.84791475 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.82444215 |
| 42 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.75555452 |
| 43 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.74226209 |
| 44 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.72926621 |
| 45 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.72507319 |
| 46 | Peroxisome_Homo sapiens_hsa04146 | 0.71206168 |
| 47 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.70824606 |
| 48 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.70756963 |
| 49 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.69397351 |
| 50 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.67983377 |
| 51 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.65837707 |
| 52 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.65206757 |
| 53 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.63721705 |
| 54 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.63408466 |
| 55 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.62781134 |
| 56 | Metabolic pathways_Homo sapiens_hsa01100 | 0.61490722 |
| 57 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.60822534 |
| 58 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.59985728 |
| 59 | Sulfur relay system_Homo sapiens_hsa04122 | 0.58837975 |
| 60 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.58829737 |
| 61 | Legionellosis_Homo sapiens_hsa05134 | 0.58394140 |
| 62 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.58099230 |
| 63 | Allograft rejection_Homo sapiens_hsa05330 | 0.57598905 |
| 64 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.56576472 |
| 65 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.56547661 |
| 66 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.55059272 |
| 67 | Asthma_Homo sapiens_hsa05310 | 0.54626775 |
| 68 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.51443040 |
| 69 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.50943239 |
| 70 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.49862596 |
| 71 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.49789006 |
| 72 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.47270439 |
| 73 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.47048949 |
| 74 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.46418825 |
| 75 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.44812757 |
| 76 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.43360604 |
| 77 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.43163119 |
| 78 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.42909396 |
| 79 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.42197756 |
| 80 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.42197329 |
| 81 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.41500367 |
| 82 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.39118126 |
| 83 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.36699231 |
| 84 | Phagosome_Homo sapiens_hsa04145 | 0.36394279 |
| 85 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.36278268 |
| 86 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.35548731 |
| 87 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.34263211 |
| 88 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.34049921 |
| 89 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.33817603 |
| 90 | Phototransduction_Homo sapiens_hsa04744 | 0.33256417 |
| 91 | Shigellosis_Homo sapiens_hsa05131 | 0.33162985 |
| 92 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.32780414 |
| 93 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.32573334 |
| 94 | Retinol metabolism_Homo sapiens_hsa00830 | 0.30429543 |
| 95 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.29715080 |
| 96 | Carbon metabolism_Homo sapiens_hsa01200 | 0.29665985 |
| 97 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.26633973 |
| 98 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.25857840 |
| 99 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.25716153 |
| 100 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.25155226 |
| 101 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.23826927 |
| 102 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.23091915 |
| 103 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.22939050 |
| 104 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.22227242 |
| 105 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.20671749 |
| 106 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.20029860 |
| 107 | Alcoholism_Homo sapiens_hsa05034 | 0.19437887 |
| 108 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.19174401 |
| 109 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.17916710 |
| 110 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.17644682 |
| 111 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.17457959 |
| 112 | Galactose metabolism_Homo sapiens_hsa00052 | 0.16204655 |
| 113 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.15602996 |
| 114 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.14956318 |
| 115 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.14898299 |
| 116 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.13942481 |
| 117 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.12986402 |
| 118 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.12003694 |
| 119 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.11670875 |
| 120 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.11271951 |
| 121 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.11220563 |
| 122 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.09564458 |
| 123 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.08856301 |
| 124 | HTLV-I infection_Homo sapiens_hsa05166 | 0.08812005 |
| 125 | Measles_Homo sapiens_hsa05162 | 0.08199207 |
| 126 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.07891285 |
| 127 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.07751828 |
| 128 | Apoptosis_Homo sapiens_hsa04210 | 0.07068626 |

